Goldman Sachs’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,367
Closed -$86K 5587
2019
Q4
$86K Buy
+5,367
New +$77.2K ﹤0.01% 5067

Other funds holding VSTM

Goldman Sachs's VSTM Position: Q1 2026 in Review

Goldman Sachs reduced its Verastem (VSTM) stake by 0.76% in Q1 2026, selling an estimated $70.4K and leaving 1,484,003 shares worth $7.87M. The position accounts for ﹤0.01% of the portfolio, ranked #3267.

Goldman Sachs first reported a position in VSTM in Q2 2013 and has held it in 45 quarters since. The position peaked at $11.5M in Q4 2025. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.

  • Goldman Sachs held 1,484,003 shares of Verastem worth $7.87M as of Q1 2026.
  • Goldman Sachs sold 11,421 Verastem shares in Q1 2026, an estimated $70.4K.
  • Verastem made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3267 holding.
  • Goldman Sachs first reported a position in Verastem in Q2 2013 and has held it in 45 quarters since.
  • Goldman Sachs's Verastem position peaked at $11.5M in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.